SCHEMBL31433112

SCHEMBL31433112

COCOc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 9/20 0.70
MAPT P10636 4/20 0.70
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
HTT P42858 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
HPGD P15428 2/20 0.70
CYP2C19 P33261 1/20 0.70
RECQL P46063 1/20 0.70
BLM P54132 1/20 0.70
SMAD3 P84022 1/20 0.70
PRMT1 Q99873 1/20 0.70
ACE2 Q9BYF1 1/20 0.70
CYP3A4 P08684 2/20 0.69
LMNA P02545 3/20 0.61
ALDH1A1 P00352 3/20 0.61
USP2 O75604 1/20 0.61
GPR55 Q9Y2T6 2/20 0.54
ALOX12 P18054 2/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10103168 1.00 FTO (0.70) FTOMAPTMEN1KMT2AHTT
SCHEMBL14750866 0.93 CYP3A4 (0.78) FTOMAPTMEN1KMT2AHTT
SCHEMBL28552749 0.92 FTO (0.61) FTOMAPTMEN1KMT2AHTT
SCHEMBL15143759 0.89 FTO (0.61) FTOMAPTMEN1KMT2AHTT
SCHEMBL3164943 0.89 CYP3A4 (0.87) FTOMAPTMEN1KMT2AHTT
SCHEMBL20777535 0.89 MAPT (0.67) FTOMAPTMEN1KMT2AHTT
SCHEMBL20280256 0.88 CYP3A4 (0.73) FTOMAPTMEN1KMT2AHTT
SCHEMBL19153208 0.88 FTO (0.75) FTOMAPTMEN1KMT2AHTT
SCHEMBL6622095 0.88 FTO (0.79) FTOMAPTMEN1KMT2AHTT
SCHEMBL29469741 0.88 FTO (0.79) FTOMAPTMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250127933-A1 Method of verifying effectiveness and stability of linker in Drug Delivery system and Structure therefor INDUSTRY-ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIVERSITY (KR) 2025-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250127933-A1 Method of verifying effectiveness and stability of linker in Drug Delivery system and Structure therefor DHFR, FOLR1, FURIN FTO 3409/4885MAPT 2175/4885MEN1 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.